+1 (713) 400-6400
3200 Southwest Fwy #2240 Phoenix TowerHouston, TX 77027
© 2020 Marker Therapeutics, Inc.
Marker Therapeutics has emerged out of a merger with Tapimmune to push forward new cell-based cancer vaccines.
President and CEO, Peter L. Hoang, will be participating at the Tumor Targeted Lymphocyte Summit.
Get Marker News Delivered To Your Inbox